chrX-11120954-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005333.5(HCCS):āc.569A>Gā(p.Lys190Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000179 in 112,031 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 1 hem., cov: 24)
Consequence
HCCS
NM_005333.5 missense
NM_005333.5 missense
Scores
5
12
Clinical Significance
Conservation
PhyloP100: 4.58
Genes affected
HCCS (HGNC:4837): (holocytochrome c synthase) The protein encoded by this gene is an enzyme that covalently links a heme group to the apoprotein of cytochrome c. Defects in this gene are a cause of microphthalmia syndromic type 7 (MCOPS7). Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jan 2010]
ARHGAP6 (HGNC:676): (Rho GTPase activating protein 6) This gene encodes a member of the rhoGAP family of proteins which play a role in the regulation of actin polymerization at the plasma membrane during several cellular processes. This protein is thought to have two independent functions, one as a GTPase-activating protein with specificity for RhoA, and another as a cytoskeletal protein that promotes actin remodeling. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21534795).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HCCS | NM_005333.5 | c.569A>G | p.Lys190Arg | missense_variant | 6/7 | ENST00000380762.5 | |
HCCS | NM_001122608.3 | c.569A>G | p.Lys190Arg | missense_variant | 6/7 | ||
HCCS | NM_001171991.3 | c.569A>G | p.Lys190Arg | missense_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HCCS | ENST00000380762.5 | c.569A>G | p.Lys190Arg | missense_variant | 6/7 | 1 | NM_005333.5 | P1 | |
HCCS | ENST00000380763.7 | c.569A>G | p.Lys190Arg | missense_variant | 6/7 | 1 | P1 | ||
HCCS | ENST00000321143.8 | c.569A>G | p.Lys190Arg | missense_variant | 6/7 | 2 | P1 | ||
ARHGAP6 | ENST00000657361.1 | c.1733-909T>C | intron_variant | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 112031Hom.: 0 Cov.: 24 AF XY: 0.0000292 AC XY: 1AN XY: 34233
GnomAD3 genomes
AF:
AC:
2
AN:
112031
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34233
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 29
GnomAD4 exome
Cov.:
29
GnomAD4 genome AF: 0.0000179 AC: 2AN: 112031Hom.: 0 Cov.: 24 AF XY: 0.0000292 AC XY: 1AN XY: 34233
GnomAD4 genome
AF:
AC:
2
AN:
112031
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
34233
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 03, 2022 | The c.569A>G (p.K190R) alteration is located in exon 6 (coding exon 5) of the HCCS gene. This alteration results from a A to G substitution at nucleotide position 569, causing the lysine (K) at amino acid position 190 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;T;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M
MutationTaster
Benign
N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MutPred
Loss of ubiquitination at K190 (P = 0.0412);Loss of ubiquitination at K190 (P = 0.0412);Loss of ubiquitination at K190 (P = 0.0412);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at